Helicobacter pylori infection and normal colorectal mucosa-adenomatous polyp-adenocarcinoma sequence: A meta-analysis of 27 case-control studies

Colorectal Disease

Volumn 16, Issue 4, 2014, Pages 246-252

  Wang, F ^a   Sun, M Y ^a   Shi, S L ^a   Lv, Z S ^b  

^a TIANJIN PEOPLE'S HOSPITAL   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Adenomatous polyps; Bacteria; Colorectal neoplasms; Helicobacter pylori; Meta analysis

Indexed keywords

CAGA PROTEIN;

ADENOMATOUS POLYP; ARTICLE; BACTERIAL STRAIN; CANCER RISK; CASE CONTROL STUDY; COLON MUCOSA; COLORECTAL CARCINOMA; DISEASE ASSOCIATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; META ANALYSIS; PATHOGENICITY; PRIORITY JOURNAL;

ADENOMATOUS POLYPS; BACTERIA; COLORECTAL NEOPLASMS; HELICOBACTER PYLORI; META-ANALYSIS;

ADENOCARCINOMA; ADENOMATOUS POLYPS; COLONIC POLYPS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINAL MUCOSA; MALE; ODDS RATIO; RISK FACTORS;

EID: 84896034712     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12290     Document Type: Article

References (45)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
2. Soylu A, Ozkara S, Alis H, et al. Immunohistochemical testing for Helicobacter pylori existence in neoplasms of the colon. BMC Gastroenterol 2008; 8: 35.
3. Maggio-Price L, Treuting P, Zeng W, Tsang M, Bielefeldt-Ohmann H, Iritani BM. Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice. Cancer Res 2006; 66: 828-38.
4. Moss S, Calam J. Helicobacter pylori and peptic ulcers: the present position. Gut 1992; 33: 289-92.
5. Dooley CP, Cohen H, Fitzgibbons PL, et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 1989; 321: 1562-6.
6. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.
7. Clarke M, Horton R. Bringing it all together: Lancet-Cochrane collaborate on systematic reviews. Lancet 2001; 357: 1728.
8. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.
9. Egger M. Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
10. Egger M, Smith GD. Misleading meta-analysis. BMJ 1995; 311: 753-4.
11. Athanasiou T, Al-Ruzzeh S, Kumar P, et al. Off-pump myocardial revascularization is associated with less incidence of stroke in elderly patients. Ann Thorac Surg 2004; 77: 745-53.
12. Zhang Y, Hoffmeister M, Weck MN, Chang-Claude J, Brenner H. Helicobacter pylori infection and colorectal cancer risk: evidence from a large population-based case-control study in Germany. Am J Epidemiol 2012; 175: 441-50.
13. Strofilas A, Lagoudianakis EE, Seretis C, et al. Association of Helicobacter pylori infection and colon cancer. J Clin Med Res 2012; 4: 172-6.
14. Hong SN, Lee SM, Kim JH, et al. Helicobacter pylori infection increases the risk of colorectal adenomas: cross-sectional study and meta-analysis. Dig Dis Sci 2012; 57: 2184-94.
15. Abbass K, Gul W, Beck G, Markert R, Akram S. Association of Helicobacter pylori infection with the development of colorectal polyps and colorectal carcinoma. South Med J 2011; 104: 473-6.
16. Inoue I, Mukoubayashi C, Yoshimura N, et al. Elevated risk of colorectal adenoma with Helicobacter pylori-related chronic gastritis: a population-based case-control study. Int J Cancer 2011; 129: 2704-11.
17. Alsamak FF, Abdulamir AS, Mahdi LK, Alnaib K, Bakar FA. Association of Helicobacter pylori with colorectal cancer development. Asian Biomed 2010; 4: 609-18.
18. Engin AB, Karahalil B, Engin A, Karakaya AE. Oxidative stress, Helicobacter pylori, and OGG1 Ser326Cys, XPC Lys939Gln, and XPD Lys751Gln polymorphisms in a Turkish population with colorectal carcinoma. Genet Test Mol Biomarkers 2010; 14: 559-64.
19. Bae RC, Jeon SW, Cho HJ, Jung MK, Kweon YO, Kim SK. Gastric dysplasia may be an independent risk factor of an advanced colorectal neoplasm. World J Gastroenterol 2009; 15: 5722-6.
20. Buso AG, Rocha HL, Diogo DM, Diogo PM, Diogo-Filho A. Seroprevalence of Helicobacter pylori in patients with colon adenomas in a Brazilian university hospital. Arq Gastroenterol 2009; 46: 97-101.
21. Bulajic M, Stimec B, Ille T, et al. PCR detection of Helicobacter pylori genome in colonic mucosa: normal and malignant. Prilozi 2007; 28: 25-38.
22. Jones M, Helliwell P, Pritchard C, Tharakan J, Mathew J. Helicobacter pylori in colorectal neoplasms: is there an aetiological relationship? World J Surg Oncol 2007; 5: 51.
23. Zumkeller N, Brenner H, Chang-Claude J, Hoffmeister M, Nieters A, Rothenbacher D. Helicobacter pylori infection, interleukin-1 gene polymorphisms and the risk of colorectal cancer: evidence from a case-control study in Germany. Eur J Cancer 2007; 43: 1283-9.
24. Machida-Montani A, Sasazuki S, Inoue M, et al. Atrophic gastritis, Helicobacter pylori, and colorectal cancer risk: a case-control study. Helicobacter 2007; 12: 328-32.
25. Georgopoulos SD, Polymeros D, Triantafyllou K, et al. Hypergastrinemia is associated with increased risk of distal colon adenomas. Digestion 2006; 74: 42-6.
26. Fujimori S, Kishida T, Kobayashi T, et al. Helicobacter pylori infection increases the risk of colorectal adenoma and adenocarcinoma, especially in women. J Gastroenterol 2005; 40: 887-93.
27. Mizuno S, Morita Y, Inui T, et al. Helicobacter pylori infection is associated with colon adenomatous polyps detected by high-resolution colonoscopy. Int J Cancer 2005; 117: 1058-9.
28. Bombski G, Gasiorowska A, Orszulak-Michalak D, et al. Elevated plasma gastrin, CEA, and CA 19-9 levels decrease after colorectal cancer resection. Int J Colorectal Dis 2003; 18: 148-52.
29. Konturek PC, Bielanski W, Konturek SJ, et al. Progastrin and cyclooxygenase-2 in colorectal cancer. Dig Dis Sci 2002; 47: 1984-91.
30. Limburg PJ, Stolzenberg-Solomon RZ, Colbert LH, et al. Helicobacter pylori seropositivity and colorectal cancer risk: a prospective study of male smokers. Cancer Epidemiol Biomarkers Prev 2002; 11: 1095-9.
31. Hartwich J, Konturek SJ, Pierzchalski P, et al. Molecular basis of colorectal cancer - role of gastrin and cyclooxygenase-2. Med Sci Monit 2001; 7: 1171-81.
32. Siddheshwar RK, Muhammad KB, Gray JC, Kelly SB. Seroprevalence of Helicobacter pylori in patients with colorectal polyps and colorectal carcinoma. Am J Gastroenterol 2001; 96: 84-8.
33. Shmuely H, Passaro D, Figer A, et al. Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol 2001; 96: 3406-10.
34. Fireman Z, Trost L, Kopelman Y, Segal A, Sternberg A. Helicobacter pylori: seroprevalence and colorectal cancer. Isr Med Assoc J 2000; 2: 6-9.
35. Breuer-Katschinski B, Nemes K, Marr A, et al. Helicobacter pylori and the risk of colonic adenomas. Colorectal Adenoma Study Group. Digestion 1999; 60: 210-15.
36. Thorburn CM, Friedman GD, Dickinson CJ, Vogelman JH, Orentreich N, Parsonnet J. Gastrin and colorectal cancer: a prospective study. Gastroenterology 1998; 115: 275-80.
37. Meucci G, Tatarella M, Vecchi M, et al. High prevalence of Helicobacter pylori infection in patients with colonic adenomas and carcinomas. J Clin Gastroenterol 1997; 25: 605-7.
38. Moss SF, Neugut AI, Garbowski GC, Wang S, Treat MR, Forde KA. Helicobacter pylori seroprevalence and colorectal neoplasia: evidence against an association. J Natl Cancer Inst 1995; 87: 762-3.
39. Zumkeller N, Brenner H, Zwahlen M, Rothenbacher D. Helicobacter pylori infection and colorectal cancer risk: a meta-analysis. Helicobacter 2006; 11: 75-80.
40. Zhao YS, Wang F, Chang D, Han B, You DY. Meta-analysis of different test indicators: Helicobacter pylori infection and the risk of colorectal cancer. Int J Colorectal Dis 2008; 23: 875-82.
41. Covacci A, Censini S, Bugnoli M, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90: 5791-5.
42. Atherton JC, Cao P, Peek RM Jr, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270: 17771-7.
43. Blaser MJ, Perez-Perez GI, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111-15.
44. Banatvala N, Mayo K, Megraud F, Jennings R, Deeks JJ, Feldman RA. The cohort effect and Helicobacter pylori. J Infect Dis 1993; 168: 219-21.
45. Kosunen TU, Aromaa A, Knekt P, et al. Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect 1997; 119: 29-34.